Show simple item record

dc.identifier.urihttp://hdl.handle.net/11401/76858
dc.description.sponsorshipThis work is sponsored by the Stony Brook University Graduate School in compliance with the requirements for completion of degree.en_US
dc.formatMonograph
dc.format.mediumElectronic Resourceen_US
dc.language.isoen_US
dc.publisherThe Graduate School, Stony Brook University: Stony Brook, NY.
dc.typeDissertation
dcterms.abstractScience research in the twenty-first century increasingly results in powerful and rapidly disseminated technologies that raise concerns over technological risk and public safety. A common recommendation for assessing and managing controversial research is to perform a quantitative risk-benefit analysis (RBA) in order to help determine an appropriate course of action. However, these recommendations lack guidelines on how to perform such an assessment. This dissertation lays out a detailed argument why a quantitative RBA should not be used as a basis for making complex policy decisions. Rather, RBA should be regarded as a tool for exploring the impacts of technology on society. This argument is made in four parts: (1) a comparison of the various legitimate, but incomparable ways that research benefits are assessed; (2) a guide to the many value-laden assumptions made in risk assessments that undermine unqualified claims of objectivity and neutrality; (3) a clarifying discussion of the technological risk attitudes that underlie research controversies; and (4) a discussion of how this inherent subjectivity favors particular risk management techniques. In applying these arguments to the use of RBA for controversial research, the concern is that RBA is unlikely to build consensus because the results of even the most mathematically sophisticated assessments tend to be too epistemically narrow or ethically controversial to resolve science policy disputes. These arguments are applied to a contemporary case study – controversial “gain-of-function†research involving highly pathogenic avian influenza. My analysis argues that the debate should place less emphasis on attempts to quantify current risks and benefits which are, in themselves, controversial. Rather, the least problematic resolution requires shifting away from traditional biosafety and biosecurity measures and towards more inherently safe research techniques that accomplish the same goals. This analysis is applicable to other contemporary research controversies such as those surrounding synthetic biology and geoengineering.
dcterms.available2017-09-20T16:51:20Z
dcterms.contributorFerguson, Daviden_US
dcterms.contributorReaven, Sheldon Jen_US
dcterms.contributorTonjes, Daviden_US
dcterms.contributorFerson, Scott.en_US
dcterms.creatorRozell, Daniel
dcterms.dateAccepted2017-09-20T16:51:20Z
dcterms.dateSubmitted2017-09-20T16:51:20Z
dcterms.descriptionDepartment of Technology, Policy, and Innovation.en_US
dcterms.extent216 pg.en_US
dcterms.formatApplication/PDFen_US
dcterms.formatMonograph
dcterms.identifierhttp://hdl.handle.net/11401/76858
dcterms.issued2015-12-01
dcterms.languageen_US
dcterms.provenanceMade available in DSpace on 2017-09-20T16:51:20Z (GMT). No. of bitstreams: 1 Rozell_grad.sunysb_0771E_12600.pdf: 1645608 bytes, checksum: 845b2141b65729c520d6d55690c67328 (MD5) Previous issue date: 1en
dcterms.publisherThe Graduate School, Stony Brook University: Stony Brook, NY.
dcterms.subjectPublic policy
dcterms.subjectavian influenza, inherent safety, R&D, risk analysis, technological risk attitudes, values
dcterms.titleOn Using Risk-Benefit Analysis to Assess and Manage Controversial Research
dcterms.typeDissertation


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record